Discontinued — last reported Q4 '25
Other operating expenses
Vertex Pharmaceuticals Other operating expenses remained flat by 0.0% to $200.00K in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising operational complexity or inefficient cost management, while a decrease suggests improved expense control or reduced non-core operational activity.
Detailed definition
This metric represents miscellaneous operating costs that do not fall under primary expense categories such as cost of g...
Peer comparison
Peers in the energy infrastructure sector typically report this as a small percentage of total operating expenses; significant deviations often warrant investigation into accounting reclassifications.
other_operating_expensesHistorical Data
| FY'25 | |
|---|---|
| Value | $800.00K |
Other operating expenses at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other operating expenses?
- Vertex Pharmaceuticals (VRTX) reported other operating expenses of $200.00K in Q4 2025.
- What does other operating expenses mean?
- Miscellaneous operational costs that are not categorized as primary production or administrative expenses.